173 related articles for article (PubMed ID: 33325126)
1. After their wives have delivered, a lot of men like going out: Perceptions of HIV transmission risk and support for HIV prevention methods during breastfeeding in sub-Saharan Africa.
Flax VL; Hawley I; Ryan J; Chitukuta M; Mathebula F; Nakalega R; Seyama L; Taulo F; van der Straten A;
Matern Child Nutr; 2021 Apr; 17(2):e13120. PubMed ID: 33325126
[TBL] [Abstract][Full Text] [Related]
2. Depression Among Pregnant and Breastfeeding Persons Participating in Two Randomized Trials of the Dapivirine Vaginal Ring and Oral Pre-Exposure Prophylaxis (PrEP) in Malawi, South Africa, Uganda, and Zimbabwe.
Stoner MCD; Mathebula F; Sedze N; Seyama L; Mohuba R; Fabiano Z; Etima J; Young A; Scheckter R; van der Straten A; Piper J; Noguchi L; Montgomery ET; Balán IC
AIDS Behav; 2024 Jul; 28(7):2264-2275. PubMed ID: 38526641
[TBL] [Abstract][Full Text] [Related]
3. Sexual Attitudes, Beliefs, Practices, and HIV Risk During Pregnancy and Post-delivery: A Qualitative Study in Malawi, South Africa, Uganda, and Zimbabwe.
Ryan JH; Young A; Musara P; Reddy K; Macagna N; Guma V; Seyama L; Piper J; van der Straten A;
AIDS Behav; 2022 Mar; 26(3):996-1005. PubMed ID: 34907478
[TBL] [Abstract][Full Text] [Related]
4. Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: the multisite MAMMA study.
van der Straten A; Ryan JH; Reddy K; Etima J; Taulo F; Mutero P; Taylor J; Piper J; Musara P;
J Int AIDS Soc; 2020 Jun; 23(6):e25536. PubMed ID: 32524700
[TBL] [Abstract][Full Text] [Related]
5. Acceptability and Use of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) During Breastfeeding in South Africa, Malawi, Zimbabwe, and Uganda.
Stoner MCD; Hawley I; Mathebula F; Horne E; Etima J; Kemigisha D; Mutero P; Dandadzi A; Seyama L; Fabiano Z; Scheckter R; Noguchi L; Owor M; Balkus JE; Montgomery ET
AIDS Behav; 2023 Dec; 27(12):4114-4123. PubMed ID: 37432541
[TBL] [Abstract][Full Text] [Related]
6. Men's Sexual Experiences with the Dapivirine Vaginal Ring in Malawi, South Africa, Uganda and Zimbabwe.
Montgomery ET; Katz AWK; Duby Z; Mansoor LE; Morar NS; Naidoo K; Tsidya M; Chitukuta M; Guma V; Tenza S; Leslie J; Garcia M; Naidoo S
AIDS Behav; 2021 Jun; 25(6):1890-1900. PubMed ID: 33389318
[TBL] [Abstract][Full Text] [Related]
7. ''Ask the way from those who have walked it before"-Grandmothers' roles in health-related decision making and HIV pre-exposure prophylaxis use among pregnant and breastfeeding women in sub-Saharan Africa.
Reddy K; Kemigisha D; Chitukuta M; Dadabhai S; Mathebula F; Tenza S; Palanee-Phillips T; Ryan J; Macagna N; Musara P; van der Straten A
PLoS One; 2022; 17(9):e0271684. PubMed ID: 36048767
[TBL] [Abstract][Full Text] [Related]
8. The landscape for HIV pre-exposure prophylaxis during pregnancy and breastfeeding in Malawi and Zambia: A qualitative study.
Zimba C; Maman S; Rosenberg NE; Mutale W; Mweemba O; Dunda W; Phanga T; Chibwe KF; Matenga T; Freeborn K; Schrubbe L; Vwalika B; Chi BH
PLoS One; 2019; 14(10):e0223487. PubMed ID: 31584987
[TBL] [Abstract][Full Text] [Related]
9. Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).
Ngure K; Friedland BA; Szydlo DW; Roberts ST; Garcia M; Levy L; Akello CA; Reddy K; Palanee-Phillips T; Macdonald P; Siziba B; Soto-Torres L; Hosek S; Hillier SL; Nair G; Celum C; van der Straten A
PLoS One; 2023; 18(6):e0287525. PubMed ID: 37352296
[TBL] [Abstract][Full Text] [Related]
10. Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa.
Leslie J; Kiweewa F; Palanee-Phillips T; Bunge K; Mhlanga F; Kamira B; Baeten J; Katz A; Hillier S; Montgomery E;
BMC Womens Health; 2021 Apr; 21(1):175. PubMed ID: 33892693
[TBL] [Abstract][Full Text] [Related]
11. Health facility users' knowledge, perceptions, and practices about infant feeding in the context of option B+ in South Africa: a qualitative study.
Nsibande DF; Magasana V; Zembe W; Kindra G; Mogashoa M; Goga A; Ramokolo V
Int Breastfeed J; 2022 Dec; 17(1):89. PubMed ID: 36539742
[TBL] [Abstract][Full Text] [Related]
12. How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub-Saharan Africa: a mixed methods analysis.
Roberts ST; Mancuso N; Williams K; Nabunya HK; Mposula H; Mugocha C; Mvinjelwa P; Garcia M; Szydlo DW; Soto-Torres L; Ngure K; Hosek S
J Int AIDS Soc; 2023 Nov; 26(11):e26189. PubMed ID: 37936551
[TBL] [Abstract][Full Text] [Related]
13. A qualitative study to explore daily versus on-demand oral pre-exposure prophylaxis (PrEP) in young people from South Africa, Uganda and Zimbabwe.
Dietrich JJ; Ahmed N; Tshabalala G; Wu M; Mulaudzi M; Hornschuh S; Atujuna M; Muhumuza R; Ssemata AS; Stranix-Chibanda L; Nematadzira T; Bekker LG; Martinson N; Seeley J; Fox J
PLoS One; 2023; 18(6):e0287627. PubMed ID: 37384792
[TBL] [Abstract][Full Text] [Related]
14. Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial.
Pleasants E; Tauya T; Reddy K; Mirembe BG; Woeber K; Palanee-Phillips T; Zimba C; Atujuna M; Montgomery ET;
AIDS Behav; 2020 Mar; 24(3):866-880. PubMed ID: 31111297
[TBL] [Abstract][Full Text] [Related]
15. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
Haribhai S; Khadka N; Mvududu R; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
Int J STD AIDS; 2023 Jul; 34(8):548-556. PubMed ID: 36947792
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.
Price JT; Wheeler SB; Stranix-Chibanda L; Hosek SG; Watts DH; Siberry GK; Spiegel HM; Stringer JS; Chi BH
J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 2(Suppl 2):S145-53. PubMed ID: 27355502
[TBL] [Abstract][Full Text] [Related]
17. Impact of the Dapivirine Vaginal Ring on Sexual Experiences and Intimate Partnerships of Women in an HIV Prevention Clinical Trial: Managing Ring Detection and Hot Sex.
Laborde ND; Pleasants E; Reddy K; Atujuna M; Nakyanzi T; Chitukuta M; Naidoo S; Palanee-Phillips T; Baeten JM; Montgomery ET;
AIDS Behav; 2018 Feb; 22(2):437-446. PubMed ID: 29151197
[TBL] [Abstract][Full Text] [Related]
18. Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa-study protocol for a mixed-methods study including a randomised controlled trial.
Nash S; Dietrich J; Ssemata AS; Herrera C; O'Hagan K; Else L; Chiodi F; Kelly C; Shattock R; Chirenje M; Lebina L; Khoo S; Bekker LG; Weiss HA; Gray C; Stranix-Chibanda L; Kaleebu P; Seeley J; Martinson N; Fox J;
Trials; 2020 Oct; 21(1):900. PubMed ID: 33121503
[TBL] [Abstract][Full Text] [Related]
19. Preferences for oral PrEP dosing among adolescent boys and young men in three sub-Saharan African countries.
Kakande A; Ssemata AS; Muhumuza R; Atujuna M; Abaasa A; Ndekezi D; Tshabalala G; Nematadzira T; Hornschuh S; Nomvuyo M; Ahmed N; Maluadzi M; Anne Weiss H; Webb E; Stranix-Chibanda L; Janine Dietrich J; Seeley J; Fox J
PLoS One; 2023; 18(10):e0285132. PubMed ID: 37812644
[TBL] [Abstract][Full Text] [Related]
20. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
